# Aripiprazole

## Abilify Maintena inj 400mg

##### 

| 藥品代碼   | IABI                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|:-----------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症     | Bipolar I disorder， Schizophrenia，                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 用法用量   | 400 mg once monthly (doses should be separated by more than 26 days); Tolerability should be established using oral aripiprazole prior to initiation of parenteral therapy; due to the half-life of oral aripiprazole it may take up to 2 weeks to fully assess tolerability. Continue oral aripiprazole (or other oral antipsychotic) for 14 days during initiation of parenteral therapy.                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 肝功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 腎功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 禁忌       | Hypersensitivity to aripiprazole or any component of the formulation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 副作用     | Headache， asthenia， accidental injury， peripheral edema， hypertension， GI disturbances， myalgia， agitation， anxiety， insomnia， lightheadedness， somnolence， akathisia， extrapyramidal syndrome， tremor， increased salivation， rhinitis， pharyngitis， coughing， blurred vision. Endocrine metabolic: Weight increased (2% to 30% ) Gastrointestinal: Constipation (5% to 11% )， Nausea (8% to 15% )， Vomiting (3% to 11% ) Neurologic: Akathisia (2% to 25% )， Dizziness (4% to 10% )， Extrapyramidal disease (2% to 27.3% )， Headache (12% to 27% )， Insomnia (8% to 18% )， Sedated (1% to 8% )， Somnolence (5% to 26.3% )， Tremor (2% to 11.8% ) Ophthalmic: Blurred vision (3% to 8% ) Psychiatric: Anxiety (4% to 17% )， Restlessness (2% to 12% ) Other: Fatigue (2% to 11% ) |
| 孕期建議   | No (limited) human data – animal data suggest low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 哺乳期建議 | No (Limited) Human Data - Potential Toxicity 無(很少)資料 - 避免使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |

## Abilify 5mg

##### 

| 藥品代碼   | OABI                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|:-----------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症     | Schizophrenia in adults & adolescents 13-17 years. Monotherapy or adjunctive therapy to either lithium or valproate for the acute manic & mixed episodes associated with Bipolar I disorder in adults & pediatrics 10-17 years. Adjunctive treatment of major depressive disorders. Irritability associated with autistic disorder in pediatric patients 6-17 years.                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 用法用量   | Maintenance for acute schizophrenia & bipolar disorder: 10 or 15 mg once daily. Max of 30 mg/day. Adjunctive therapy for major depressive disorder: Initial dose: 2-5 mg/day. Max of 15 mg/day.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 肝功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 腎功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 禁忌       | Known hypersensitivity to aripiprazole.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 副作用     | Headache， asthenia， accidental injury， peripheral edema， hypertension， GI disturbances， myalgia， agitation， anxiety， insomnia， lightheadedness， somnolence， akathisia， extrapyramidal syndrome， tremor， increased salivation， rhinitis， pharyngitis， coughing， blurred vision. Endocrine metabolic: Weight increased (2% to 30% ) Gastrointestinal: Constipation (5% to 11% )， Nausea (8% to 15% )， Vomiting (3% to 11% ) Neurologic: Akathisia (2% to 25% )， Dizziness (4% to 10% )， Extrapyramidal disease (2% to 27.3% )， Headache (12% to 27% )， Insomnia (8% to 18% )， Sedated (1% to 8% )， Somnolence (5% to 26.3% )， Tremor (2% to 11.8% ) Ophthalmic: Blurred vision (3% to 8% ) Psychiatric: Anxiety (4% to 17% )， Restlessness (2% to 12% ) Other: Fatigue (2% to 11% ) |
| 孕期建議   | Human data suggest low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 哺乳期建議 | No (Limited) Human Data - Potential Toxicity 無(很少)資料 - 避免使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |

